Equitec Proprietary Markets’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-84,943
| Closed | -$11.6M | – | 76 |
|
|
2018
Q2 | $11.6M | Buy |
+84,943
| New | +$7.71M | 2.91% | 6 |
|
|
2017
Q4 | – | Sell |
-400
| Closed | -$16K | – | 99 |
|
|
2017
Q3 | $16K | Buy |
+400
| New | +$15.4K | ﹤0.01% | 86 |
|
|
2017
Q1 | – | Sell |
-32,492
| Closed | -$811K | – | 126 |
|
|
2016
Q4 | $575K | Buy |
32,492
+7,569
| +30% | +$163K | 0.02% | 67 |
|
|
2016
Q3 | $582K | Buy |
+24,923
| New | +$566K | 0.03% | 64 |
|
|
2016
Q2 | – | Sell |
-20,047
| Closed | -$362K | – | 168 |
|
|
2016
Q1 | $364K | Sell |
20,047
-45,222
| -69% | -$729K | 0.03% | 75 |
|
|
2015
Q4 | $1.38M | Buy |
65,269
+33,762
| +107% | +$651K | 0.07% | 52 |
|
|
2015
Q3 | $581K | Sell |
31,507
-27,792
| -47% | -$694K | 0.03% | 72 |
|
|
2015
Q2 | $2.01M | Sell |
59,299
-17,898
| -23% | -$720K | 0.12% | 50 |
|
|
2015
Q1 | $3.71M | Buy |
77,197
+12,710
| +20% | +$577K | 0.29% | 32 |
|
|
2014
Q4 | $1.43M | Buy |
+64,487
| New | +$1.49M | 0.06% | 70 |
|
Equitec Proprietary Markets's FMI Position: Q3 2018 in Review
Equitec Proprietary Markets sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 84,943 shares — an estimated $11.6M sold.
Equitec Proprietary Markets first reported a position in FMI in Q4 2014 and held it in 10 quarters. The position peaked at $11.6M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- Equitec Proprietary Markets reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- Equitec Proprietary Markets sold 84,943 Foundation Medicine, Inc. shares in Q3 2018, an estimated $11.6M.
- Equitec Proprietary Markets first reported a position in Foundation Medicine, Inc. in Q4 2014 and held it in 10 quarters.
- Equitec Proprietary Markets's Foundation Medicine, Inc. position peaked at $11.6M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on Equitec Proprietary Markets's 13F filing for Q3 2018, filed 15 Oct 2018.